Literature DB >> 7697276

Parenteral application of a Pseudomonas aeruginosa flagella vaccine elicits specific anti-flagella antibodies in the airways of healthy individuals.

G Döring1, C Pfeiffer, U Weber, A Mohr-Pennert, F Dorner.   

Abstract

To test the hypothesis that a Pseudomonas aeruginosa flagella (FLA) vaccine, intramuscularly administered, elicits specific antibodies in the respiratory tract, antibody titers against FLA were determined in sera and bronchoalveolar lavage (BAL) fluids of 10 healthy human adults before and after immunization. Immunization produced significantly increased anti-FLA antibody titers in all sera (mean reciprocal titers: IgG: 26,711; IgA: 2,767; IgM: 421) and on respiratory epithelial lining fluids (mean reciprocal titers: IgG: 112; IgA: 76; sIgA: 26). Significant differences in class-specific serum and BAL anti-FLA titers suggested airway antibody production. The study shows that parenteral immunization provides not only high systemic antibody titers but also local antibody production in the human respiratory tract.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7697276     DOI: 10.1164/ajrccm.151.4.7697276

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  13 in total

1.  Vaccine strategies against cystic fibrosis pathogens.

Authors:  Vincent Le Moigne; Jean-Louis Gaillard; Jean-Louis Herrmann
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

Review 2.  Recent developments for Pseudomonas vaccines.

Authors:  Anurag Sharma; Anja Krause; Stefan Worgall
Journal:  Hum Vaccin       Date:  2011-10-01

3.  Poliovirus-specific immunoglobulin A in persons vaccinated with inactivated poliovirus vaccine in The Netherlands.

Authors:  M M Herremans; A M van Loon; J H Reimerink; H C Rümke; H G van der Avoort; T G Kimman; M P Koopmans
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

4.  Protection against fatal Pseudomonas aeruginosa pneumonia in mice after nasal immunization with a live, attenuated aroA deletion mutant.

Authors:  Gregory P Priebe; Gloria J Meluleni; Fadie T Coleman; Joanna B Goldberg; Gerald B Pier
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

5.  Flagella, Chemotaxis and Surface Sensing.

Authors:  Miguel A Matilla; Félix Velando; Elizabet Monteagudo-Cascales; Tino Krell
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

6.  A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients.

Authors:  Gerd Döring; Christoph Meisner; Martin Stern
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-21       Impact factor: 11.205

7.  Identification of broadly protective human antibodies to Pseudomonas aeruginosa exopolysaccharide Psl by phenotypic screening.

Authors:  Antonio DiGiandomenico; Paul Warrener; Melissa Hamilton; Sandrine Guillard; Peter Ravn; Ralph Minter; Maria Margarita Camara; Vignesh Venkatraman; Randall S Macgill; Jia Lin; Qun Wang; Ashley Elaine Keller; Jessica C Bonnell; Mladen Tomich; Lutz Jermutus; Michael P McCarthy; David A Melnick; Joann A Suzich; C Kendall Stover
Journal:  J Exp Med       Date:  2012-06-25       Impact factor: 14.307

8.  Assessment of pulmonary antibodies with induced sputum and bronchoalveolar lavage induced by nasal vaccination against Pseudomonas aeruginosa: a clinical phase I/II study.

Authors:  Ulrich Baumann; Kerstin Göcke; Britta Gewecke; Joachim Freihorst; Bernd Ulrich von Specht
Journal:  Respir Res       Date:  2007-08-05

9.  Development of a broad spectrum glycoconjugate vaccine to prevent wound and disseminated infections with Klebsiella pneumoniae and Pseudomonas aeruginosa.

Authors:  Nicolas Hegerle; Myeongjin Choi; James Sinclair; Mohammed N Amin; Morgane Ollivault-Shiflett; Brittany Curtis; Rachel S Laufer; Surekha Shridhar; Jerod Brammer; Franklin R Toapanta; Ian Alan Holder; Marcela F Pasetti; Andrew Lees; Sharon M Tennant; Alan S Cross; Raphael Simon
Journal:  PLoS One       Date:  2018-09-06       Impact factor: 3.240

10.  Defining the Mechanistic Correlates of Protection Conferred by Whole-Cell Vaccination against Pseudomonas aeruginosa Acute Murine Pneumonia.

Authors:  Catherine B Blackwood; Annalisa B Huckaby; Emel Sen-Kilic; Alexander M Horspool; Kelly L Weaver; Aaron C Malkowski; William T Witt; Justin R Bevere; F Heath Damron; Mariette Barbier
Journal:  Infect Immun       Date:  2021-01-19       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.